30 Turbo Cancer Treatment race is on: Johnson & Johnson just completed $2 billion cancer drug buy of Ambrx on March 7, 2024 - Merck, Novartis, Sanofi, Eli Lilly, AbbVie, Pfizer, BMS - they all want in! (twitter.com) posted 259 days ago by brain_dead 259 days ago by brain_dead +30 / -0 10 comments share 10 comments share save hide report block hide replies
Yes. I have friends and family who took that shit. One of them is now turbo cancer of the epithelial. So damn sad.